A Phase II Study of Neoadjuvant Chemotherapy Followed by Extended Field Concurrent Chemoradiotherapy for Para-aortic Lymph Node Positive Cervical Cancer

被引:10
作者
Shimoji, Yuko [1 ]
Nagai, Yutaka [1 ,3 ,4 ]
Toita, Takafumi [2 ,5 ]
Ariga, Takuro [2 ,6 ]
Heianna, Joichi [2 ]
Nakasone, Tadaharu [1 ]
Taira, Yusuke [1 ]
Arakaki, Yoshihisa [1 ]
Nakamoto, Tomoko [1 ]
Ooyama, Takuma [1 ]
Kudaka, Wataru [1 ]
Kaneshima, Itomi [1 ]
Nishihira, Kumiko [1 ]
Mekaru, Keiko [1 ]
Aoki, Yoichi [1 ]
机构
[1] Univ Ryukyus, Grad Sch Med, Dept Obstet & Gynecol, 207 Uehara Nishihara, Nishihara, Okinawa 9030215, Japan
[2] Univ Ryukyus, Grad Sch Med, Dept Radiol, Nishihara, Okinawa, Japan
[3] Okinawa Prefectural Nanbu Med Ctr, Dept Obstet & Gynecol, Haebaru, Okinawa, Japan
[4] Childrens Med Ctr, Haebaru, Okinawa, Japan
[5] Okinawa Chubu Hosp, Dept Radiat Therapy Ctr, Uruma, Okinawa, Japan
[6] Univ Ryukyus Hosp, Hlth Informat Management Ctr, Nishihara, Okinawa, Japan
关键词
Cervical cancer; para-aortic node metastasis; neoadjuvant chemotherapy; extended-field concurrent chemoradiotherapy; phase II study; RADIATION-THERAPY; CISPLATIN CHEMOTHERAPY; CARCINOMA; SURVIVAL; IRRADIATION; TRIAL; RADIOTHERAPY; PATTERNS; HEAD;
D O I
10.21873/anticanres.14346
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: We conducted a phase II study of neoadjuvant chemotherapy followed by extended field concurrent chemoradiotherapy in patients with cervical cancer with para-aortic node metastasis. Patients and Methods: Thirty-seven women with stage IB1-IVA cervical cancer were enrolled. Results: The median age was 52 years. Thirty-four patients other than 3 progressive disease, proceeded to extended field concurrent chemoradiotherapy. The 3-year overall survival and progression-free survival rates were 70.1% and 48.5%, respectively. The 3-year overall survival according to stages was significantly worse in stage IIIB. Twelve of the 17 patients with stage IIIB died of the disease. Conclusion: Neoadjuvant chemotherapy followed by extended field concurrent chemoradiotherapy may improve the prognosis of patients with stages IB and II cervical cancer with positive para-aortic node. However, new strategies should be investigated to improve a poor prognosis in stage IIIB disease with positive para-aortic node.
引用
收藏
页码:3565 / 3570
页数:6
相关论文
共 27 条
[1]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[2]   Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies? [J].
Benito, Virginia ;
Carballo, Sonia ;
Silva, Patricia ;
Esparza, Miriam ;
Arencibia, Octavio ;
Federico, Mario ;
Andujar, Miguel ;
Mori, Marta ;
Medina, Norberto ;
Lubrano, Amina .
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2017, 24 (04) :609-616
[3]   SURVIVAL AND PATTERNS OF RECURRENCE IN CERVICAL-CANCER METASTATIC TO PERIAORTIC LYMPH-NODES - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
BERMAN, ML ;
KEYS, H ;
CREASMAN, W ;
DISAIA, P ;
BUNDY, B ;
BLESSING, J .
GYNECOLOGIC ONCOLOGY, 1984, 19 (01) :8-16
[4]   Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer [J].
Chen, MD ;
Paley, PJ ;
Potish, RA ;
Twiggs, LB .
GYNECOLOGIC ONCOLOGY, 1997, 67 (02) :131-136
[5]   Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial [J].
da Costa, Samantha Cabral S. ;
Bonadio, Renata Colombo ;
Gabrielli, Flavia Carolina G. ;
Aranha, Andrea S. ;
Dias Genta, Maria Luiza N. ;
Miranda, Vanessa C. ;
de Freitas, Daniela ;
Abdo Filho, Elias ;
Ferreira, Patricia A. O. ;
Machado, Karime K. ;
Scaranti, Mariana ;
Carvalho, Heloisa de A. ;
Estevez-Diz, Maria Del Pilar .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (33) :3124-+
[6]   Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): Phase III Clinical Trial Comparing Surgical With Radio logic Staging in Patients With Stages IB2-IVA Cervical Cancer [J].
Frumovitz, Michael ;
Querleu, Denis ;
Gil-Moreno, Antonio ;
Morice, Philippe ;
Jhingran, Anuja ;
Munsell, Mark F. ;
Macapinlac, Homer A. ;
LeBlanc, Eric ;
Martinez, Alejandra ;
Ramirez, Pedro T. .
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2014, 21 (01) :3-8
[7]   Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes [J].
Grigsby, PW ;
Heydon, K ;
Mutch, DG ;
Kim, RY ;
Eifel, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :982-987
[8]   Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes [J].
Grigsby, PW ;
Perez, CA ;
Chao, KSC ;
Herzog, T ;
Mutch, DG ;
Rader, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (03) :733-738
[9]   Safety of combining radiotherapy with immune-checkpoint inhibition [J].
Hwang, William L. ;
Pike, Luke R. G. ;
Royce, Trevor J. ;
Mahal, Brandon A. ;
Loeffler, Jay S. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (08) :477-494
[10]   5-YEAR SURVIVAL OF PATIENTS WITH PERIAORTIC NODAL METASTASES IN CLINICAL STAGE-IB AND STAGE-IIA CERVICAL-CARCINOMA [J].
LOVECCHIO, JL ;
AVERETTE, HE ;
DONATO, D ;
BELL, J .
GYNECOLOGIC ONCOLOGY, 1989, 34 (01) :43-45